Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (131-140 of 243) with videos related to

Pageof 25
Sort By:
Scientific Reports|March 26, 2022
Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workersPascale Huynen, Céline Grégoire, Stéphanie Gofflot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2010
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioningFrédéric Baron, Chantal Lechanteur, Evelyne Willems, et al.
Bulletin Du Cancer|July 21, 2023
[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Anne Conrad, Yves Beguin, Sarah Guenounou, et al.
Scientific Reports|June 13, 2022
Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workersCéline Grégoire, Pascale Huynen, Stéphanie Gofflot, et al.
Oncotarget|May 14, 2016
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myelomaMarilène Binsfeld, Joséphine Muller, Virginie Lamour, et al.
Iscience|February 27, 2023
Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cellsCaroline Ritacco, Murat Cem Köse, Justine Courtois, et al.
Leukemia|September 15, 2025
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasiaDaniel Pollyea, Tessa Kerre, Dries Deeren, et al.
European Journal of Haematology|December 30, 2017
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific surveyTimothy Devos, Yves Beguin, Lucien Noens, et al.
Cancers|September 9, 2022
Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) ScoresAdrien De Voeght, Evelyne Willems, Sophie Servais, et al.
Hematological Oncology|March 2, 2019
Dual-tracer PET/CT scan after injection of combined [<sup>18</sup> F]NaF and [<sup>18</sup> F]FDG outperforms MRI in the detection of myeloma lesionsNadia Withofs, Yves Beguin, François Cousin, et al.
Pageof 25

Showing results (131-140 of 243) with videos related to

Sort By:
Pageof 25
Scientific Reports|March 26, 2022
Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workersPascale Huynen, Céline Grégoire, Stéphanie Gofflot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2010
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioningFrédéric Baron, Chantal Lechanteur, Evelyne Willems, et al.
Bulletin Du Cancer|July 21, 2023
[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Anne Conrad, Yves Beguin, Sarah Guenounou, et al.
Scientific Reports|June 13, 2022
Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workersCéline Grégoire, Pascale Huynen, Stéphanie Gofflot, et al.
Oncotarget|May 14, 2016
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myelomaMarilène Binsfeld, Joséphine Muller, Virginie Lamour, et al.
Iscience|February 27, 2023
Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cellsCaroline Ritacco, Murat Cem Köse, Justine Courtois, et al.
Leukemia|September 15, 2025
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasiaDaniel Pollyea, Tessa Kerre, Dries Deeren, et al.
European Journal of Haematology|December 30, 2017
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific surveyTimothy Devos, Yves Beguin, Lucien Noens, et al.
Cancers|September 9, 2022
Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) ScoresAdrien De Voeght, Evelyne Willems, Sophie Servais, et al.
Hematological Oncology|March 2, 2019
Dual-tracer PET/CT scan after injection of combined [<sup>18</sup> F]NaF and [<sup>18</sup> F]FDG outperforms MRI in the detection of myeloma lesionsNadia Withofs, Yves Beguin, François Cousin, et al.
Pageof 25